Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:phenytoin
|
| gptkbp:ATCCode |
gptkb:N03AB02
|
| gptkbp:contraindication |
hypersensitivity to phenytoin
|
| gptkbp:drugClass |
anticonvulsant
|
| gptkbp:eliminationHalfLife |
22 hours
|
| gptkbp:excretion |
urine
|
| gptkbp:FDAApproved |
yes
|
| gptkbp:form |
extended-release capsule
|
| https://www.w3.org/2000/01/rdf-schema#label |
Phenytek
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
Mylan Pharmaceuticals
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
D
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
rash drowsiness ataxia |
| gptkbp:usedFor |
epilepsy
seizure disorder |
| gptkbp:bfsParent |
gptkb:diphenylhydantoin
|
| gptkbp:bfsLayer |
7
|